Firefly Neuroscience, Inc. 是一家人工智慧(AI)科技公司,致力於為精神疾病和神經系統疾病開發神經科學解決方案。公司總部位於紐約州肯莫爾,目前擁有13名全職員工。該公司已開發出獲得美國FDA 510(k)許可的腦網路分析軟體平台(BNA平台),專注於推進針對患有精神疾病和認知障礙患者的診斷與治療方法,包括憂鬱症、失智症、焦慮症、腦震盪以及注意力不足/過動症。該公司的腦網路分析工具是一種神經生理評估工具,利用人工智慧與機器學習技術來分析休息狀態與認知活動期間所記錄的腦波圖(EEG)數據。BNA平台結合腦電系統,為臨床醫生提供有關大腦功能(認知)的全面洞察。
AIFF stock price ended at $1.9 on 星期四, after dropping 1.55%
On the latest trading day May 07, 2026, the stock price of AIFF fell by 1.55%, dropping from $1.95 to $1.90. During the session, the stock saw a volatility of 6.56%, with prices oscillating between a daily low of $1.83 and a high of $1.95. On the latest trading day, the trading volume for AIFF decreased by 25.8K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 356.1K shares were traded, with a market value of approximately $28.1M.